They are different molecules targeting partially overlapping but distinct receptor pathways
A simple concentration mistake turns a therapeutic dose into a sub-therapeutic one (wasting money and time) or an overdose (risking serious side effects)
You are currently pregnant or planning pregnancy
Head-to-head comparison The cleanest comparison so far is SURPASS-2, which pitted tirzepatide against semaglutide 1 mg in adults with type 2 diabetes (not the obesity dose, but still the most rigorous head-to-head we have)
Legality at the state level, however, does not equal federal regulatory clearance, third-party verification, or confirmed sterility of individual batches
Compounded 2.5mg/ml Injectable Semaglutide Suggested Dose: Inject 0.1ml once weekly subcutaneously weeks 1-4, Increase dose to 0.2ml once weekly on weeks 5-8, increase dose to 0.4ml once weekly on weeks 9-12, increase dose to 0.68ml once weekly on weeks 13-16, if a dosage increase is still needed, increase to 0.96ml once weekly for maintenance